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INCREASING SPECIFIC ACTIVITY OF NAD+ DEPENDENT Q105R 
MUTANT OF CANDIDA METHYLICA FORMAT DEHYDROGENASE 
SUMMARY 
NAD+-dependent FDHs (EC 1.2.1.2) use sodium formate as the substrate and catalyze 
convertion of sodium formate ion into CO2. At the same time, NAD
+ is reduced into 
NADH form. Because of low redox potential, NAD+-dependent FDHs are mostly used 
enzymes in the industrial area and they provide NADH regeneration for the synthesiz 
of optical chiral compounds. NAD+-dependent FDHs have some disadvantages such 
as low specific activity and they can be inactivated at high temperatures especially 
when they are used in the industrial area. Recently, protein engineering studies are 
aimed to overcome these disadvantages. 
In this study, we used site-directed mutagenesis method for increasing specific activity 
of Q105R mutant Candida methylica FDH whose thermostability was increased. In 
the previous studies, K328V mutation has been introduced into the Q105R mutant of 
Candida methylica FDH due to the specific activity of K328V mutation was increased 
at Candida boidinii FDH. First we have designed primer that codes valine residue at 
328th position. Site directed mutagenesis method has been performed by using the 
designed primers. Then  PCR products have been digested by DpnI enzyme which cuts 
methylated adenine site. Digested DNA fragments carrying the required double mutant 
(K328V on Q105R) have been cloned into pQE-2 vector then transformed into BL-21 
chemical competent cells. Three random colonies have been chosen and purified at the 
end of the transformation. Purified plasmids have been sent for DNA sequence 
analysis. The accuracy of mutation has been checked by comparing with DNA 
sequence. Mutant K328V cells have been cultivated for kinetic measurement and then 
protein purification has been carried out for cultivation of the cells. Purified protein 
has been run on SDS-PAGE and chosen fractions have been collected for kinetic 
measurement analysis. The kinetic measurement has been carried out at 25 oC at 340 
nm wavelength with constant NAD+ concentration (4 mM) and changing substrate 
concentrations (0-80 mM). To calculate Km and kcat value, Hyper32 programme has 
been used. Calculated Km and kcat value reveals that K328V mutation decreases 
specific activity and Km value. 
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NAD+-BAĞIMLI MUTANT Q105R CANDIDA METHYLICA FORMAT 
DEHİDROGENAZIN SPESİFİK AKTİVİTESİNİN ARTIRILMASI 
ÖZET 
NAD+-bağımlı format dehidrogenazlar (EC 1.2.1.2) sodyum formatı substrat olarak 
kullanır ve sodyum formatın CO2‘e dönüşmesini katalizler. Aynı zamanda, NAD+‘i 
NADH formuna indirger. NAD+-bağımlı FDH’ler, düşük redoks potansiyelinden 
dolayı, saf kiral bileşiklerin sentezlenmesinde gerekli olan NADH rejenerasyonunu 
sağlamak için endüstriyel alanda en çok kullanılan enzimlerden biridir. NAD+-bağımlı 
FDH’lerin düşük aktivite göstermesi ve yüksek sıcaklıkta inaktif olması, bu enzimlerin 
endüstriyel alanda kullanımı açısından bir dezavantaj yaratmaktadır. Son zamanlarda 
yapılan protein mühendisliği çalışmaları ile bu dezavantajları en aza indirgemek 
amaçlanmıştır.  
Oksidoredüktaz enziminin alt sınıfında yer alan dehidrogenaz enzimleri optikçe aktif 
maddelerin sentezlenmesinde etkilidirler. Dehidrogenaz sınıfı içerisinde yer alan 
format dehidrogenazlar (FDH) koenzimlerin rejenerasyonu açısından -özellikle 
NAD(P)+ rejenerasyonu- endüstriyel ve kimyasal alanda tercih edilen bir enzim haline 
gelmiştir. Özellikle format dehidrogenazın katalizlediği reaksiyonlarda substrat olarak 
kullanılan sodyum format bileşiğinin çok ucuz maliyetinin olması ve kolayca elde 
edilebilir olması, katalizlenen reaksiyon sonucu oluşan karbon dioksitin (CO2) 
reaksiyon ortamından kolayca uzaklaştırılabilmesi, format dehidrogenaz enziminin 
çok geniş bir pH aralığında (6.0-9.0) etkinlik gösterebilme kapasitesi ve reaksiyon 
sonucu oluşan ürün veriminin fazla olması, format dehidrogenazın endüstriyel alanda 
daha fazla tercih edilmesini sağlamaktadır. Aynı zamanda endüstriyel uygulamalarda 
format dehidrogenaz enziminin yüksek sıcaklıklarda kullanılması enzimin 
aktivitesinde büyük dezavantaj teşkil etmektedir (50-60°C arasında  enzim aktivitesi 
yarıya düşmekte, daha yüksek sıcaklıklarda enzim inaktif olmaktadır). Bu nedenden 
dolayı, son zamanlarda endüstriyel alanda sıcaklığa dayanıklı enzimler geliştirme 
ihtiyacı ortaya çıkmıştır. Bu ihtiyacı karşılamak üzere son yıllarda protein 
mühendisliği çalışmaları büyük ölçüde önem kazanmıştır.  
Geçmiş çalışmalarda FDH’in aktivitesini artırmak üzere birçok organizmada 
çalışmalar yapılmış ve elde edilmiş olan mutant FDH’ler yabanıl tipteki FDH’ler ile 
karşılaştırılmıştır. Candida boidini’de (Cb)`den izole edilen FDH`in 23. pozisyonunda 
bulunan sistein aminoasiti serin aminoasitine (C23S), 285. pozisyondaki fenilalanin 
aminoasiti serin aminoasitine (F285S) dönüştürülerek spesifik aktivitenin 
artırılmasına çalışılmıştır. Sodyum format ve  NAD+ ya karşı kinetik ölçümler yapılmış 
ve spesifik aktivitede yaklaşık 1.7 kat artış olduğu gözlemlenmiştir. Candida boidini 
için yapılan bir diğer çalışmada ise 195., 196., 356. ve 379. pozisyonlarda bulunan 
aminoasitlere odaklanılmış ve NAD+ ye karşı aktif mutant FDH’ler elde edilmiştir 
fakat sodyum format ve koenzimler için herhangi bir Km değeri belirtilmemiştir. 
Saccharomyces cerevisiae FDH’i (ScFDH) için 196. ve 197. pozisyonlardaki 
aminoasitler üzerine çalışma yapılmış olup, yapılan çalışmalar sonucu koenzim 
xxii 
 
seçiciliğinin NAD+ dan NADP+ ya değiştiği gözlemlenmiştir. Yine spesifik aktiviteyi 
artırmak amacıyla Pseudomonas sp.101. FDH’e yönelik (PseFDH) birçok çalışma 
yapılmış olup özellikle 131., 160., 168., 184. ve 228. pozisyonunda bulunan serin 
aminoasitlerinin alanin aminoasitine dönüştürülerek elde edilmiş olan mutantlar 
yabanıl tipteki PseFDH’ler ile karşılaştırılmış ve kinetik değerlerde değişme olmadığı 
saptanmıştır. 
Candida methylica FDH (CmFDH) için yapılmış olan geçmiş çalışmalarda 195. ve 
221. pozisyondaki asparajin aminoasiti serin aminoasiti ile değiştirilmiş olup elde 
edilmiş olan mutantların yabanıl tipe oranla NAD+ koenzimi için spesifik aktivitesinin 
daha düşük olduğu gözlemlenmiştir. Yine aynı organizma için 169. ve 226. 
pozisyonundaki treonin aminoasitleri valin aminoasitine dönüştürülmüş, 169. 
pozisyonda yapılmış olan mutasyonun kinetik ölçümleri sonucu Kcat değerinde 
yaklaşık 4 kat azalma olduğu, bu mutasyonun 226. pozisyondaki mutasyonla beraber 
gerçekleştirildiğinde ise kinetik değerinde herhangi bir değişim gözlemlenmemiştir. 
Daha çok elektrostatik etkileşim elde etmek amacıyla Candida methylica FDH’sinde 
13., 105., 147., 160., 187. ve 302. pozisyonlarda mutasyonlar yapılmış olup, elde 
edilmiş bu mutantlar tek tek ve ikili veya daha fazla kombinasyonları denenmiş olup 
sodyum formata karşı aktivitesi artırılamamıştır. 
Bu çalışmada, daha önceden termal stabilitesi artırılmış olan Candida methylica 
FDH’nin (Q105R) spesifik aktivitesinin artırılması için protein mühendisliği 
yöntemlerinden birisi olan yönlendirilmiş-bölge mutagenez yöntemi kullanılmıştır. 
Geçmiş çalışmalarda, Candida boidinii FDH’inde (cbFDH) K328V mutasyonunun 
spesfik aktivitesinin artırılmasından dolayı Q105R mutant Candida methylica 
FDH’inin (cmFDH) üzerine K328V mutasyonu uygulanmıştır. İlk olarak, 328. 
pozisyonda lizin aminoasidini kodlayan (K328V) AAA kodonunun yerine, valin 
aminoasidini kodlayan GTT kodonunu içeren primer dizayn edilmiştir. Dizayn edilen 
primerler ile yönlendirilmiş-bölge mutagenez polimeraz zincir reaksiyonu (PZR) 
yapılmıştır. PZR sonucunda elde edilen PZR ürünleri agaroz jel elektroforezinde 
yürütülüp, yürütülen jel UV altında görüntülenerek yaklaşık 6000 baz çiftine (bp) denk 
gelen bir bant gözlemlenmiş olup PZR ürünlerinin doğruluğu kontrol edilmiştir. Daha 
sonra PZR ürünleri DpnI enzimi ile metillenmiş adenin kısmından kesilmiştir ve 
mutasyon içermeyen DNA’ların uzaklaştırılması sağlanmıştır. Kesilmiş DNA 
fragmentlerini içeren çift mutant (Q105R/K328V) taşıyan PZR ürünleri pQE-2 
vektörü içerisine klonlanıp, daha sonra BL-21 kimyasal kompetent hücreleri içerisine 
transforme edilmiş ve transforme olmuş hücreler ampisilin içeren katı besiyerine ekim 
yapılarak 16-20 saat boyunca 37 oC de büyütülmeye bırakılmıştır. Transformasyon 
sonucunda büyüyen kolonilerden üç tanesi rastgele seçilerek plazmid izolasyon işlemi 
yapılmıştır. İzole edilmiş olan plazmitler, öncelikle agaroz jelde kontrol edilmiş daha 
sonra mutasyonun doğruluğunu saptamak amacıyla DNA dizi analizi için 
gönderilmiştir. Mutasyonun doğruluğunu tespit etmek amacıyla BioEdit programı 
kullanılmış, elde edilmiş olan mutantlar cmFDH DNA dizisi ile karşılaştırılarak 
mutasyonun doğruluğu kontrol edilmiştir. Mutant Q105R/K328V kinetik enzim 
ölçümleri yapılmak üzere, mutant hücreler transforme edildikten sonra ampisilin 
içeren Luria-Bertani (LB) katı besiyerinde 16-20 saat boyunca 37 oC de büyütülmüş 
ve büyütülmüş olan hücrelerden protein saflaştırması yapılmak üzere tek koloni 
alınarak ampisilin içeren 50 ml LB sıvı besiyerine ekimi yapılıp 1 gece boyunca 
bekletilmiştir. Bekletilmiş olan kültür ampisilin içeren 1 L lik sıvı besiyerine transfer 
edilmiş olup OD600 değeri yaklaşık 0.6 ya ulaştığında kültür içeresine IPTG eklenerek 
protein ekpresyonu indüklenmesi sağlanmıştır. İndüklenmiş proteinler HisTrap 
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yöntemi kullanılarak saflaştırılmıştır. Saflaştırılan proteinler SDS-PAGE’de 
yürütülmüş ve belirlenen protein fraksiyonları kinetik ölçümlerde kullanılması için 
toplanmıştır. Kinetik ölçümler, sabit NAD+ konsantrasyonunda (4 mM) ve değişen 
sodyum format konsantrasyonlarında (0-80 mM) 25 oC ’de 340 nm dalga boyunda 
gerçekleştirilmiştir. Km ve kcat değerlerinin hesaplanmasında Hyper32 programı 
kullanılmıştır. Hesaplanmış Km ve kcat değerleri Q105R/K328V mutasyonunun 
spesifik aktiviteyi ve Km değerini düşürdüğü göstermiştir. 
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1 
 INTRODUCTION 
 Enzymes 
Enzymes are catalysers in the biological mechanisms and they are responsible for the 
all metabolic pathways in living organisms. They increase specificity and velocity of 
metabolic chemical reactions about 1012-fold. Although most of the enzymes are in 
protein structure, a small group of them are catalytic RNA like ribozymes [1]. The 
conformation of enzymes in protein structure which include primary, secondary, 
tertiary, quaternary structure affect their catalytic activity. Some factors can affect the 
catalytic activity of the enzymes. For example: if enzymes are denatured by 
temperature, pH etc. or separated to their subunits, they can lose their function. In 
addition, when enzymes are degraded into amino acids which built them, their activity 
can also be negatively affected [1]. 
While some enzymes that do not require any side group can work alone, others require 
one or more inorganic group which are called cofactor like Fe2+, Mg2+, Zn2+ or need 
organic molecules which are called coenzymes such as biyositine, coenzyme A. 
Coenzymes, and cofactors can be tightly bound to enzymes or form covalent bonds. 
An enzyme which is catalytically active when it is bound to its metal ion and coenzyme 
together is called holoenzyme. Protein structures found in holoenzymes are called 
apoenzyme or apoprotein. 
Two models explain how enzymes bind their substrate. First one is” lock and key” 
model which claims that enzyme and substrate bind together by the help of their 
complementary regions. This model was suggested by Emil Fischer in 1894. However, 
nowadays, “induction-fit model” which was discovered by Daniel E. Koshland in 1958 
is much more preferred rather than “lock and key” model. This model suggests that 
when a substrate binds specific active-site of enzymes, the conformation of active site 
will change and then enzyme will cover the substrate. [1]. 
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Figure 1.1 : A simple enzymatic reaction [1]. 
1.1.1 Classification of Enzymes 
At first, enzymes were randomly named, then they were named according to the type 
of the reactions they catalyze or their binding molecules. In 1961, The International 
Union of Biochemistry determined new norms for denotation and classification of 
enzymes consisting six sub-classes which are given in Table 1. 
i. Oxidoreductases: Catalyse oxidation and reduction reaction between two substrates 
with transferring hydride ions or H atoms. 
ii. Transferases: Catalyse transfer of functional group between two substrates. 
iii. Hydrolases: Catalyse hydrolyzation of biological bonds such ether, ester, peptide, 
glycoside etc. 
iv. Lysases: Catalyse addition of groups on double bonds or change groups to form 
double bonds. 
v. Isomerases: Provides isomeration of a substrate by group transfer to the molecule. 
vi. Ligases: Catalyse condensation of two metabolites by using ATP or similar 
cofactor to synthesize a new molecule [2]. 
Table 1.1 : Classification of enzymes [1]. 
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 Formate Dehydrogenases 
Formate dehydrogenase is an enzyme which belongs to the family of oxidoreductase 
(EC 1.2.1.2, FDH). Formate dehydrogenases catalyse the  convertion of formate ions 
into carbon dioxide meanwhile NAD(P)+ is reduced to NADH(P). 
1.2.1 Dehydrogenases 
Dehydrogenases are sub-class of the oxidoreductase which catalyses oxidation-
reduction mechanism in the organism. These types of enzymes use cofactor as NAD+, 
NADP+, FAD, FMN (Flavin mononucleotide) in the enzymatic reactions. 
1.2.2 General properties of FDH 
D-specific 2-hydroxy acid dehydrogenases have belonged to FDHs. In nature, three 
types of FDH is founded. The first type of FDHs consists from archaea and anaerobic 
microorganism which contain heterooligomers with a complex quaternary structure. 
This type of FDHs are also possessed high molecular weight and can be described by 
existence of some prosthetic group such as iron-sulphur clusters, molybdenum, 
tungsten ions in the active site of them. In addition, they show too much susceptibility 
to oxygen [3]. Complex NAD+-dependent formate dehydrogenases (EC 1.2.1.2, FDH) 
are the second type of FDHs and also require heavy metals such as molybdenium, iron 
and selenium. The third one is the simplest one and called as  NAD+-dependent FDH. 
This group of enzyme have two active sites and also they do not contain metal ions or 
prosthetic groups in their structure[3]. NAD+-dependent FDHs are so important in 
terms of the catalysing of oxidation of formate anion into carbon dioxide, at the same 
time they are realized to the reduction of NAD+ to NADH which occur in the terminal 
step of the catabolism of C1 compounds in yeast and bacteria cells [4].  
At 1921, formate dehydrogenase was found firstly in a plant which is called as 
Phaseolus vulgaris. [5]. Firstly in 1951, Davison studied NADH formation by ethanol, 
succinate and glutamate in pea and bean seeds [6].  In early 1970s, FDH enzymes were 
studied in microorganisms like yeast, bacteria, and fungi. FDHs have an important role 
in the microorganisms and in plants. While at plants FDHs which biosynthesis was 
gone up the under stressful conditions are founding in mitochondria, at microorganism 
FDHs can show different properties such as in methanol-utilizing bacteria and yeast, 
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FDH uses the supply of energy for a cell, whereas in pathogenic bacteria and fungi 
FDH is found as stress protein [4]. 
An important advantage of the FDH is to catalyse the reactions which are not returned 
back which provide to get 100% yield. FDHs can be worked at different pH range 
(between 4 to 10) which most efficient range of FDH is between 6 to 9 [7]. 
1.2.3 Structural features of NAD+-dependent FDH 
The molecular mass of NAD+-dependent FDHs can change especially in some 
methylotrophic organisms. In the eukaryotic and some methylotrophic organisms it 
can be found between 70 to 100 kDa. It composes of two identical subunits which 
consist of “NAD binding domain” and “catalytic domain” [7] and neither prosthetic 
groups nor metal ions are not contained at the FDHs. In the Mycobacterium vaccae 10 
and Pseudomonas sp. 101, which is methylotrophic bacteria, are the presence of 
molybdenum their molecular mass range can be reached to nearly 450 kDa whereas 
the presence of tungsten in the growth media their molecular mass range can be 
between 80-93 kDa [4]. Generally, homodimers are formed by NAD+-dependent 
FDHs and they are considerably specific to both formate and NAD+. 
Primary structure of FDH is compared and observed greatly similarities in different 
organisms. 71 amino acid residues that consist of nearly 20% of all residues are highly 
conserved during the evolutionary period in the FDH. Moreover, they include active 
site in which occurs catalytic activity and sites, which are linked coenzyme.  
Some amino acid residues are important in the different organisms in terms of catalytic 
activity which are formed of the active side of FDH. Pro97, Phe98, Ile122, Gly123, 
Ser124, Asp125, Asn146, Thr282, Ala283, Arg284, Asp308, Gln313, and His332 are 
important amino acid residues in the Pseudomonas sp. 101 active sites that are shown 
at figure 2 [9]. Pro77, Phe78, Ile102, Asn118, Gly171, Gly173, Gly176, Arg267, 
Gln278 and His310 are important for Candida methylica FDH (cmFDH) and also 
Phe69, Asn119, Ile175, Arg258, Gln287, Pro288 and His311 position too in Candida 
boidinii FDH(cbFDH). These residues are situated in and around the catalytic site and 
have proposed binding or catalytic functions (Figure 3) [10]. 
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Figure 1.2 : Active centre of FDH from Pseudomonas sp. 101. [9]. 
 
Figure 1.3 : Active centre of FDH from Candida boidinii [10]. 
1.2.4 Catalytic properties of NAD+-dependent FDH 
Bi-Bi reaction was observed in the NAD+-dependent FDHs. In this type of reaction, 
NAD+ is used as  a first substrate and an active site functions independent of other 
active sites . A substrate which is bound to an enzyme is increased to the affinity of 
other substrate 3.5-fold. FDH catalyse the reaction by the hydride ion transfer from the 
substrate onto NAD+. This hydride ion transfers to the fourth carbon of the 
nicotinamide. This reaction is also seen in other related dehydrogenases. FDHs can 
work at the best pH values between 6.0 to 9.0 [11, 12] and activity of FDHs are 
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decreased half between 50-60 °C temperature. While FDHs can work at the wide pH 
range, they do not work at high temperatures conditions. They are inactive at the 
extreme conditions [8]. Catalytic properties of FDH at the some organism was given 
at Table 2. 
Table 1.2 : Catalytic properties of FDH at the different organism [4]. 
 
1.2.5 Practical applications of FDH 
Optically active compounds are necessary for cellular activities. Optically chiral 
compounds contain a chiral center, which consists of an asymmetric carbon which is 
bound to four different groups. Optically chiral compounds have two forms (D- and 
L-), whose mirror image does not overlap with each other, which are called 
enantiomers or optical isomers. Different enantiomers of the same compounds can 
bring about diseases due to their adverse physiological effects. According to 
prescriptions of Food and Drug Administration of USA, the optical purity of all chiral 
compounds used as drugs has to be no less than 99%. For that reason, many of 
researcher is attracted considerable attention on enzyme applications in 
pharmaceutical industry and studies were increased on pharmaceutic in the past years. 
Dehydrogenases show extreme stereospesificity when transferring the hydride ion 
between the substrate and coenzyme. Because of this, nonchiral products can be turned 
into optically active ones using dehydrogenases. These enzymes can produce optically 
active compounds with very high optical purity (around 99.9-99.99%). Using 
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dehydrogenases is also cheap when compared to NADPH and NADH (>USD 12/kg). 
To solve this problem, another reaction has been suggested to decreased of the price 
of coenzymes which is converted of NAD(P)+ to NAD(P)H which was explained at 
Figure 4  [13]. 
 
Figure 1.4 :  General scheme of conversion of NAD(P)+ to NAD(P)H [4, 8]. 
Regeneration of NAD(P)H (figure 5) can be realized with FDHs and these reactions 
are important for composed of chiral compounds in chemistry. 
 
Figure 1.5 : General scheme of NAD(P)H regeneration [12]. 
Using of FDH in the NAD(P)H regeneration reaction can be listed below;   
i. The reaction catalysed by FDHs are commonly irreversible and shifting the 
equilibrium of the main reaction by regeneration results in 99-100% yield of final 
product. 
ii. Formate is a cheap substrate which can be used in catalysed of FDHs reaction and 
comprised of CO2 in the result of reaction can be easily removed the reaction mixture.  
iii. FDHs can work at the best pH values between 6.0 to 9.0 [11]. 
iv. FDHs, especially isolated from yeast and bacteria, are stable enzymes and they are 
usually used in the system for a long time. 
EP ER 
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v. Using the methanol-utilizing yeast and bacteria can decrease the cost of production 
and they supply to produce enough enzyme in large scale. [12]. 
NAD(P)H regeneration systems which are catalysed with FDH are so important and 
appropriate in chemistry. On the other hand, FDHs which are constituted naturally are 
specific NAD+ as well. Because of the fact that, the aim of altering coenzyme 
specificity of FDH by protein engineering (NADP+ versus NAD+) has importance [7, 
8, 12, 14, 15, 16]. In recent years, various experiments were performed to alter the 
specificity of isolated from different organisms of FDH towards NADP+ have yielded 
promising results but the activity of NAD+ is so high [16, 17, 18]. 
 Protein Engineering 
Protein engineering is an important tool for creating new and improved protein. It 
provides knowledge about protein structure and function. Protein engineering has 
become a great potential and enables using various industrial applications such as 
chemical, food, textile and medical. Protein engineering is necessary for protein 
expression studies and understanding protein function. To make changes in protein 
structure, first, characteristics of wild-type proteins should be identified by analytic 
methods. New properties are introduced to protein by creating changes in the protein 
functional region of proteins. Proteins can be modified to make changes in their 
catalytic activity, for receptor binding and alteration of specificity [19]. 
Protein engineering is also used in enzymology. Especially, in the industrial process, 
temperature, pressure and pH could affect reactions. However, natural forms of 
enzymes could possess some limitations (limited substrate and coenzyme specificity 
and low kcat) in terms of stability and activity in industrial processes when they are 
subjected to extreme conditions. To solve the limitation problems, nanotechnology, 
metabolic engineering, cellular membrane engineering and protein engineering can be 
utilized [20, 22, 23]. Thanks to these alterations, especially the ones made by protein 
engineering, a gene which encodes the enzyme structure can be changed and the 
desired enzyme can be highly expressed [24].  Protein engineering can be classified 
into threemain categories: rational design,  directed evolution and semirational design. 
They provide researchers to increase the stability or activity of enzyme, coenzyme 
specificity of enzyme and overcome the substrate limitation [25].  
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The rational design gives information about structure and function of known proteins. 
Site-directed mutagenesis is the most important technique for rational design. In 
directed evolution, random mutagenesis is used and the knowledge of protein structure 
is not required. This approach makes use of mutant libraries and screening studies to 
verify desired property of enzymes. Both the strategies have a lot of advantages in the 
industrial applications for optimization of proteins while they have some limitations 
such as complexity of enzyme structure or function. To overcome the limitation, 
rational design and directed evolution were combined which is called semi-rational 
design. This strategy could be effective to solve the limitations of these strategies and 
the properties of an enzyme is developed [25, 26, 27].  
 
Figure 1.6 : General scheme of the protein engineering strategies [28]. 
1.3.1 Rational Design 
1.3.1.1 Site-directed mutagenesis 
Site-directed mutagenesis is a technique which is mostly used in protein engineering 
approach. This method helps understanding how a sequence of interest affects the gene 
and its endpoint protein product [29]. The purpose of this technique is to convert an 
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amino acid into another one at a defined site to identify the effect of the mutation on 
conformation and structure of the protein. Changing enzyme properties strongly 
requires manipulation of the primary structure of the protein. Structural and functional 
properties can be altered by single point mutations which make differences in 
electrostatic interactions of the enzyme, in disulfide bridges, core packing, condensing 
surface loops. In site-directed mutagenesis method, polymerases chain reaction (PCR) 
is used to modulate the gene sequence with designed primers for the specific region 
[30].  
Advances in protein modeling tools and knowing the three dimensional structure of a 
protein will help directed evolution studies [25, 26]. 
1.3.2 Directed Evolution 
In contrast to rational design, in this technique, information of the 3D structure of the 
protein is not required and natural evolution process is mimicked and a mutant library 
of the desired enzyme is created, selected and screened. [25, 26, 31, 32]. Directed 
evolution technique is also used for developing enzyme activity and new metabolic 
pathway. Different strategies can be used for  directed evolution. DNA shuffling and 
error prone PCR are the most preferred in the directed evolution. 
i. In error prone PCR reaction, MgCl2 is used at high concentration and therefore 
stability of non-pairing PCR product is increased. The error of margin is increased by  
MgCl2 which is used. Mutation frequency and nucleotide ratio can be determined by 
changing amount of MgCl2. The amount of template DNA which is used at the 
beginning can be altered by changing number of cycles used in the PCR reaction. 
These conditions provide alternation in a number of mutated genes [33]. 
ii. DNA shuffling is the strongest and most efficient technique used in the directed 
evolution method. This technique provides the increase in mutation number causing 
variability in DNA libraries. In addition, it contributes to recombination between 
different DNA species giving rise to different mutations. In this technique, DNA 
molecules that are created with the other methods are separated into small pieces by 
Dnaz. Then, these pieces are assembled in PCR reaction. In this PCR process, resulting 
DNA fragments are used as a primer instead of the conventional primers. At the end 
of PCR, several DNA molecules are obtained which includes different genes [34]. 
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1.3.3 Semi-rational Design 
1.3.3.1 Site-saturation mutagenesis 
The rational design gives information about structure and function of known proteins; 
in the directed evolution, the 3D structure of a protein is not required to know and 
natural evolution process is mimicked and a mutant library of the desired enzyme is 
created, selected and screened with tools [25, 31, 32]. Both of these techniques are 
useful for protein engineering but they have still a limitation in some aspect. Therefore, 
these two methods were combined to overcome the limitations. This method is called 
as semi-rational. 
In semi-rational approaches, pre-determined specific residues through the basic 
structural or functional knowledge are randomized using directed evolution tools, 
especially saturation mutagenesis, create “smarter‟ libraries that give positive results 
[20]. For using the site-saturation technique, which is usually used for creating mutant 
library, knowledge about the protein structure should be known.  In this technique, 
degenerate primers are used to form different for each amino acid residues. As a result, 
all possible amino acid types are formed at the mutant library.  
1.4 Protein Engineering of Formate Dehydrogenase  
However, FDH enzyme is used in cofactor regeneration processes. Native FDHs do 
not have much operational stability, their cofactor is not NADP+, they are not 
thermostable and cost for production is high. Because of this FDH is a good candidate 
to engineer by using protein engineering strategies [21]. 
FDHs are inactive above 55-60°C [4] so thermostability is one of the most important 
properties of the engineered FDH. This could be done by measurement of the enzyme’s 
residual activity upon incubation at a fixed temperature by introducing the Tm value 
[12]. There are several studies about improving the thermostability of FDH by either 
rational design or directed evolution.  
Studies about thermostable FDH showed different results. Rojkova et al. (1999) 
reported that hydrophobization of α-helices within the protein results in higher 
thermostability with either single or different combinations of the mutations to the 
enzyme from Pseudomonas sp.101. This enzyme is the most thermostable FDH. 
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Slusarczyk et al. (2004) used directed evolution method and got about 10-fold increase 
in thermal stability as a result. According to the research, mutating Glu151 to Asp and 
Arg178 to Ser increases thermostability. Moreover, Fedorchuck et al. (2002) 
confirmed that the interaction between the residues 43 and 61 is important. Their 
results show that electrostatic repulsion between Asp43 and Glu61 gives the FDH from 
Mycobacterium vaccae by substitution of Glu61 with a non-negatively charged amino 
acid. 
1.5 Aim of the study 
As mentioned above, because of the some features such as stability and comparatively 
production of good yield,  FDH can be used at NADH regeneration system in the many 
applications. Candida methylica FDH (cmFDH) was cloned and overproduced at the 
University of Bristol and purification processes have been improved at Department of 
Molecular Biology and Genetics of Istanbul Technical University (ITU) giving a much 
better yield. 
In the previous study, 105th amino acid position was converted glutamin (CAA) to 
arginin (AGA) for increasing Tm value and for getting to more thermostabil enzyme. 
In this study, we have designed K328V mutation for increasing the specific activity of 
Candida methylica FDH (cmFDH) mutant (Q105R) which has increased Tm value by 
site-directed mutagenesis. For this purpose, the double mutant (Q105R/K328V) of 
cmFDH have been constructed, purified and compared the activity with Q105R 
mutant. 
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 MATERIALS AND METHODS 
 Materials 
2.1.1 Laboratory equipments 
Laboratory equipments which are used in this work are given in Table 2.1. 
Table 2.1 : Laboratory Equipments. 
Equipments Trade Mark/Model 
Vortex  Scientific Industries  
pH Meter  InoLab  
Autoclaves  Tuttnauer 2540ml (Switzerland)  
Magnetic Stirrer  Heidolph  
Micropipettes  Eppendorf,Gilson  
Orbital Shaker Incubator  Biolab-Certomat (Germany)  
Microplate Shaker Incubator  Ika  
Microfuge  Microfuge 18 Beckman  
Centrifuge  Allegra 25R Centrifuge Beckman  
UV-Visible Spectrophometer  Shimadzu UV-1601 (Japan)  
Microplate Reader  Perkin Elmer  
Thermocycler  Biometra  
Cycle Sequencer  ABI 3130 Avanti  
Water-Bath Eppendorf  
Thermomixer  Eppendorf  
Deep freezers ( -80 °C )  Ultra Low Sanyo  
Freezer ( -20 °C )  Biomedical Freezer Sanyo  
Refrigerator ( +4 °C )  Arçelik (Turkey)  
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2.1.2 Enzymes, kits and chemicals 
During this study, used enzymes, kits and chemicals are given in Table 2.2. 
Table 2.2 : Chemicals, enzymes and used kits. 
 Materials Trademark 
 
 
 
 
 
 
Chemicals 
Tris-Base Carlo Erba 
Boric Acid Merck 
EDTA BDH Laboratory 
Imidazole Merck 
NaH2PO4.2H2O Sigma 
Glycose Sigma 
NADP Roche 
Formate Aldrich 
IPTG Applichem 
Sodium Asetate Fluka 
Glyserol Carlo Erba 
Ampicillin Roche 
Ethanol Merck 
Agarose Applichem 
EZ-vision Fluka 
dNTP Roche 
10X Pfu Buffer Fermentas 
Tango Buffer Fermentas 
Marker 3 “Lamda DNA” Fermentas 
 
Enzymes 
Pfu Taq Polymerase Fermentas 
PstI Fermentas 
SacI Fermentas 
DpnI Roche 
Kits 
High Pure Plasmid 
Isolation Kit 
Agilent 
 
2.1.3 Preparation of media for culture and transformation: Luria-Bertani (LB) 
and Super Optimal Broth with Catabolite repression (SOC) 
Luria-Bertani (LB) liquid and Luria-Bertani (LB) agar medium were used to grow the 
cell. The usage before, antibiotic which is called ampicillin was added to each LB 
media at the rate of 1:1000 for growing to culture. In addition, Super Optimal Broth 
with Catabolite repression (SOC) medium was used for transformation. The 
component of LB, LB with agar and SOC media are given at below. 
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Luria-Bertani (LB) media preparation : 10 g NaCl, 10 g tryptone, 5 g yeast extract 
were weighed and dissolved about 950 mL distilled water (dH2O) and final volume 
was completed 1000 mL with distilled water (dH2O). 
Luria-Bertani (LB) media with agar :  10 g NaCl, 10 g tryptone, 5 g yeast extract 
were weighed and dissolved about 900 mL distilled water (dH2O). Then, 15 g agar was 
weighed and added to the media mixture. Finally, the volume of media mixture was 
completed 1000 mL with distilled water (dH2O).   
Super Optimal Broth with Catabolite repression (SOC) preparation : 20 g 
tryptone, 5 g yeast extract, 0.58 g NaCl (final concentration 10 mM), 0.186 g KCl 
(final concentration 2.5 mM) were weighed and dissolved about 950 mL distilled water 
(dH2O) and final volume was completed 1000 mL with distilled water (dH2O).  Then, 
medium was autoclaved at 121 oC and under 1 atm pressure for 15 minutes. Finally, 
10 ml filtered MgSO4 solution (final concentration 10 mM) and 10 ml filtered glycose 
solution were added to the medium. 
2.1.4 Buffers and solutions 
2.1.4.1 TAE buffer (50X) 
50x TAE buffer was prepared for using in agarose gel electrophoresis and 50x TAE 
buffer was diluted with dH2O to 1x TAE for using to prepare agarose gel and running 
in the agarose gel tank. Preparation of 50x TAE is given in Table 2.3. 
Table 2.3 : Preparation of 50x TAE buffer. 
Content Amount 
Tris Base 242 g 
Glacial Acetic acid 57.1 mL 
EDTA 14.6 g 
dH2O 1 L 
2.1.4.2 Protein purification buffers 
Protein purification buffers were used for purifying proteins from bacterial pellet by 
HisTrap purification method metal affinity chromatography and ion-exchange 
chromatography. 
Preparation of protein purification buffers which were used in this study are given at 
below: 
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Buffer A: 3.12 g NaH2PO4.2H2O (20mM), 29.22 g NaCl (500 mM) and 2.04 g 
imidazole (30 mM) were weighed and dissolved in 950 mL dH2O and final volume 
was completed 1000 mL with distilled water (dH2O). Finally, pH was adjusted to 7.4 
using NaOH.  
Buffer B: 3.12 g NaH2PO4.2H2O (20mM), 29.22 g NaCl (500 mM) and 34.04 g 
imidazole (500 mM) were weighed and dissolved in 950 mL dH2O and final volume 
was completed 1000 mL with distilled water (dH2O). Finally, pH was adjusted to 7.4 
using NaOH. 
50 mL Buffer A + 100 mM imidazole: 42.55 mL Buffer A and 7.45 mL Buffer B is 
mixed. 
50 mL Buffer A + 200 mM imidazole: 31.9 mL Buffer A and 18.1 mL Buffer B is 
mixed. 
50 mL Buffer A + 400 mM imidazole: 10.6 mL Buffer A and 39.4 mL Buffer B is 
mixed. 
2.1.4.3 Buffers and solutions for SDS – PAGE analysis 
2.1.4.3.1 6x sample buffer 
6x sample buffer was used to denature protein samples. This buffer was mixed with 
our protein sample and was loaded on SDS- polyacrylamide gel. Preparation of 6x 
sample buffer is given at Table 2.4. 
Table 2.4 : Preparation of 6x sample buffer. 
Content Concentration Amount 
Tris-HCl pH: 6.8 0.3 M 1.25 mL (of 1 M) 
SDS 6% 6 mL (of 10%) 
Glycerol 20% 2 mL (of 100%) 
Bromophenol Blue 0.05% 5 mg 
DTT 0.15 M 231 mg 
dH2O  Up to 10 mL 
2.1.4.3.2 Tris – Tricine running buffer (10X) 
Tris-Tricine SDS Buffer (10x) was used as the electrophoresis running buffer at the 
stacking and resolve process of SDS-PAGE. Preparation of Tris-Tricine buffer is given 
at below (Table 2.5). 
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Table 2.5 :  Preparation of Tris-Tricine buffer. 
Content Concentration Amount 
Tris Base 1 M 60.55 g 
Tricine 1 M 89.60 g 
SDS 1% 5 g 
dH2O  Up to 500 mL 
2.1.4.3.3 Coomassie Brilliant Blue (CBB) stain solution 
CBB stain solution was used to visualize separated protein bands on SDS 
polyacrylamide gel. Preparation of CBB stain solution is given at Table 2.6. 
Table 2.6 : Preparation of CBB stain solution. 
Content Concentration Amount 
CBB R-250 0.1% 0.5 g 
Methanol 45% 450 mL 
Acetic Acid 10% 100 mL 
dH2O 45% 450 mL 
2.1.4.3.4 Destain solution 
Destain solution was used to remove the background on SDS polyacrylamide gel and 
protein bands is become too visible. Preparations of CBB destain solution is given at 
Table 2.7. 
Table 2.7 : Preparations of CBB destain solution. 
Content Concentration Amount 
Methanol 45% 450 mL 
Acetic Acid 10% 100 mL 
dH2O 45% 450 mL 
2.1.5 pQE – 2 expression vector 
TAGZyme pQE-2 expression vector® which is produced by Qiagen was used for 
expression of mutant cmFDH. The vector comprises of 4758 bp in length and includes 
ampicillin resistance gene as the selective marker. And also, it includes lac operator 
and lacIq repressor gene for gene expression regulation, uses T5 promoter. In addition, 
it has also 6xHis tag sequence, which facilitates the protein purification. The wild-type 
FDH coding sequence was inserted into the multiple cloning sites from SacI and PstI 
cleavage sites (Figure 2.1). 
18 
 
Figure 2.1 : pQE-2 vector [36]. 
2.1.6 BL – 21 cells 
Competent BL-21(DE3) cells which were prepared from commercial BL-21 (DE3) 
(New England Biolabs) were used for the mutagenesis production at the 
transformation process. BL-21(DE3) is used Eschericchia coli strain for protein 
expression. It includes λDE3 lysogen phage gene for the expression of T7 polymerase 
providing high levels of protein expression. Preparation of competent BL-21(DE3) cell 
is given at section 2.2.5. 
 Methods 
2.2.1 Site – directed mutagenesis 
Site-directed mutagenesis is a rational design technique.. For the increase our 
knowledge, structure of protein and function associations of the enzyme should be 
known. The aim of this technique, the desired amino acid at a defined site is altered 
into another amino acid based on conformational and structural knowledge about the 
protein. 
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First step of the design is the development of the model of the desired molecule. This 
model needs an appropriate algorithm. Experimental studies for the properties of the 
protein follows after. Rational protein design can be applied to improving the 
thermostability as it can be applied in other properties of a protein. 
Primary structure of the protein should be changed when changing the property of an 
enzyme. Even the change of a single residue will result in a drastic change of the 
structure and function of an enzyme. Electrostatic interactions would also be optimized 
with the change in the structure. Site directed mutagenesis is done by changing the 
desired sites which is defined with the computational study using polymerase chain 
reaction with spesific primers carrying the desired mutation. 
Primer Design 
In this study, we designed one set of primer for target residue (K328V). 
OligoEvaluatorTM programme (http://www.oligoevaluator.com/OligoEvaluator) was 
used for design primers whose sequences were given at table 2.8. 
Table 2.8 : Designed primers for K328V. 
Primers Sequences 
K328V-F 5’- GATACGCTGAAGGTACTGTTAATATTTTGGAATC-3’ 
K328V-R 5’- GATTCCAAAATATTAACAGTACCTTCAGCGTATC -3’ 
PCR conditions 
Site-directed mutagenesis PCR was performed to amplify for using cmFDH plasmid. 
PCR mixture and PCR condition were given at table 2.9, 2.10 and 2.11. 
Table 2.9 : Site-directed PCR mixture (HF). 
Ingredient Stock 
Concentration 
Volume Final 
Concentration 
HF buffer 5x 5 μl 0.5x 
Primer mix 10 ng/μl 1 μl 1 ng/μl 
dNTP mix 10 mM 1 μl 200 μM 
dH2O - 42.25 μl - 
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Table 2.9 (continued): Site-directed PCR mixture (HF). 
Ingredient Stock 
Concentration 
Volume Final 
Concentration 
Template DNA 203.5 ng/μl 0.25 μl 50 ng/μl 
Pfu polymerase 2 U/μl 0.5 μl 0.02 U/μl 
TOTAL  50 μl  
Table 2.10 : Site-directed PCR mixture (GC). 
Ingredient Stock 
Concentration 
Volume Final 
Concentration 
GC buffer 5x 5 μl 0.5x 
Primer mix 10 ng/μl 1 μl 1 ng/μl 
dNTP mix 10 mM 1 μl 200 μM 
dH2O - 41.25 μl - 
Template DNA 203.5 ng/μl 0.25 μl 50 ng/μl 
DMSO - 1 μl - 
Pfu polymerase 2 U/μl 0.5 μl 0.02 U/μl 
TOTAL  50 μl  
Table 2.11 : Site-directed PCR conditions. 
Cycle Number Degree Time Phase 
1 98°C 30 sec Initial 
Denaturation 
 
18 
98°C 30 sec Denaturation 
55°C 1 min Annealing 
72°C 6 min Elongation 
1 72°C 5 min Final Extension 
1 4°C ∞ Final Hold 
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2.2.2 Control of PCR products 
After the PCR reaction, PCR products are controlled in agarose gel electrophoresis. 
The size of used PCR product (plasmid) consists of about 6 kb (4758 bp pQE-2 vector 
+ 1094 bp cmFDH gene). This control is performed at 1% agarose gel (prepared of 1% 
agarose gel is given below). 5 μl of PCR products were mixed with 1 μl EZ-vision one 
DNA dye & buffer and then mixing samples are loaded into the wells. In addition, for 
determining of the size of PCR product, 3 μl DNA marker (Lambda 
DNA/EcoRI+HindIII, Marker 3® by Fermantas) was used and added into wells. 
Loaded samples were run at 120 V for 30-35 minutes and 1% agarose gel observed 
under UV light. 
2.2.3 DpnI treatment 
After controlled of PCR products at the 1% agarose gel electrophoresis, PCR products 
were digested with DpnI enzyme, which identifies the methylated adenine sites, the 
methylated DNA and dam+ strains, which is given restriction site at Figure 8. 
Therefore, the vector, which carries to original DNA sequence, was removed from the 
PCR product that includes dam+ strain. In this study, we treated to 40 μl of PCR 
product with added on 1 μl DpnI enzyme. The reaction was performed reaction at 37°C 
for 2 hours. 
 
Figure 2.2 : Restriction site of DpnI. 
2.2.4 Competent cell preparation 
In this study, we prepared BL-21 chemical competent cells from using commercial 
BL-21 cells (New England Biolabs) for transforming of mutagenesis PCR product. 
The preparation of BL-21 competent cells are given at below: 
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 Cells are taken from the glycerol stock and cultivated into LB-Amp plate with 
a needle. Cultivated plates were incubated at orbital shaker at 37 °C for 16-20 
hours. 
 A single colony was picked up from plates and it was cultivated into 5 μl LB-
liquid and again was incubated at orbital shaker at 37 °C for 16-20 hours. 
 1 mL of incubated cells were taken and cultivated into 50 mL LB-liquid media 
and were incubated at orbital shaker at 37 °C until OD600 reach to 0.4-0.6. 
 Incubated cells were transferred into 50 mL falcon tubes and waited on ice for 
10 minutes. 
 Waited falcon tubes were centrifuged at 5000 rpm for 10 minutes. 
 The supernatant was discarded and the pellet was resuspended with 30 mL cold 
80 mM MgCl2 + 20 mM CaCl2 and waited on ice for 5 minutes (This step is 
repeated for 2 times). 
 Falcon tubes were centrifuged at 5000 rpm for 10 minutes. 
 Pellets were resuspended with 100 mM CaCl2 + 15% glycerol solution. This 
mixture was aliquoted into 50-100 μl eppendorf tubes and was kept at -80°C. 
2.2.5 Transformation 
PCR products that are digested with DpnI were transformed into BL-21 chemical 
competent cells. On this purpose, 0.5 of PCR product was added into 50 μl BL21 
chemical competent cell and tube was waited on ice for 30 minutes. Then, tubes was 
waited into water-bath at 42°C for 30-45 seconds, immediately tube was put on the ice 
and was waited for 1-2 minutes. After this step, 250 μl S.O.C medium was added into 
tube and tube was shaken at orbital shaker at 37 °C for 1 hour. Finally, 50-100 μl of 
transformation product was taken and spread on LB-Agar-Amp plate. The plate was 
incubated overnight at 37 °C. 
2.2.6 Mutation confirmation 
For the mutation confirmation, 4 colonies were picked randomly and cultured through 
overnight incubation at 37°C, then plasmid DNA was isolated as mentioned in section 
2.2.8. 
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2.2.7 PstI / SacI restriction 
For the mutation confirmation, isolated plasmid DNA was digested by SacI/PstI 
restriction enzymes, in order to accuracy of cmFDH gene if inserted into SacI/PstI 
restriction sites of the PQE-2 vector. In this study, 2.5 μl of plasmid DNA was digested 
with SacI: PstI (1:1 units) for 2 hours at 37°C. 
2.2.8 Plasmid isolation 
This process was performed with StrataPrep Plasmid Miniprep Kit by Agilent. 
A single colony was taken from LB-Agar-Amp plate and each colony was inoculated 
into the 5 ml LB liquid medium containing 100 μg/ml ampicillin. Cells were incubated 
at 37°C for 16 hours. 1.5 ml of cell cultures are aliquoted into a 1.5 mL eppendorf 
tube. Tubes are centrifuged at 13000 rpm for 1 minute. After centrifugation, 
supernatant phase is removed and discarded. 100 -l of solution is added to the 
eppendorf tube. Tube is vortexing or pipeting to resuspend and completely disperse 
the cells. 100 l of solution-2 is added to the eppendorf tube. Tube is mixed gently 
until homogenous by inverting the tube several times. 125 l of solution-3 is added to 
the eppendorf tube. The tube is mixed by inverting the tube several times. The tube is 
centrifuged at 13000 rpm for 5 minutes. Then supernatant is transferred into high pure 
filter which is placed in a 2-ml receptacle tube. Tube is centrifuged at 13000 rpm for 
30 seconds for passing of liquid and our plasmid DNA is clinged to filter. The liquid 
that passed through the collection tube is discarded. 750 μl of Nuclease Removal 
Buffer is added onto filter tube and is centrifuged at 13000 rpm for 30 seconds. The 
liquid that passed through the collection tube is discarded again. 750 μl of 1x Wash 
Buffer is added onto filter tube for washing of our plasmid. Then, tube is centrifuged 
at 13000 rpm for 30 seconds, liquid phase is removed and again tube is centrifuged at 
13000 rpm for 30 seconds. Finally, 50 μl of Elution Buffer is loaded onto filter tube 
for eluting to plasmid and is waited at room temperature for 5 minutes. Tube is 
centrifuged at 13000 rpm for 1 minute. The eluted plasmid DNA was measured at 
nanodrop for controlling of concentration. Content of the solution-1-2, elution and 1x 
Wash Buffer is given at Table 2.12. 
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Table 2.12 : Content of plasmid purification kit of solutions. 
Solution 1 Solution 2 Elution Buffer 2xWash Buffer 
50 mM Tris-HCl  
(pH: 7.5) 
0.2 M NaOH 10 mM Tris Base 
Adjust pH: 8.5 
with HCl 
10 mM Tris-HCl  
(pH: 7.5) 
10 mM EDTA 1% (w/v) SDS  100 mM NaCl 
50 μg/mL RNaseA    2.5 mM EDTA 
2.2.9 Sequence analysis 
Sequence analysis was performed from isolated plasmid DNA which was purified 
from the transformed colonies which were picked randomly. Sequence of the 
mutantion was controlled and compared with native cmFDH by BioEdit programme. 
2.2.10 Expression of cmFDH protein 
pQE-2 vector with cloned cmFDH gene was transformed into BL21 competent cells. 
A single colony was chosen from transformed mutant and native cmFDH. Native and 
mutant cmFDH were inoculated into 50 ml LB-liquid media in flasks which contain 
50 μl ampicillin. Then, flasks were incubated at orbital shaker for overnight at 37oC. 
The next day, growing pre-cultures were transferred into 1 L LB-liquid media (this 
media contains 1 mL ampicillin) and culture was incubated OD600 value of cultures 
reaches 0.6. Then, 1 M IPTG was added into culture (final concentration of IPTG is 
0.1 mM) and waited at 37oC for 4 hours due to induce protein expression. Finally, 
expressed culture was centrifuged at 5000 rpm for 15 minutes and pellets were stored 
at -20 oC. 
2.2.11 HisTrap purification of 6xHis tagged cmFDH protein 
After precipitation of cells containing mutant FDH proteins, purification protocol of 
proteins were performed as follows; precipitated cells treated with Lysis buffer which 
contains 5 mL Buffer A+5mg lysozyme and cells was resuspended completely. 
Resuspended cells were waited on ice for 1 hour. Then resuspended cells were 
disrupted by sonication (20 sec pulse on/20 sec pulse off). Sonicated cells were 
centrifuged at 5000 rpm for 20 minutes and supernatant which is called clarified lysate 
was transferred into new falcon tubes. Clarified lysate was filtered with 0.45 μl for 2 
times. Filtered lysate was loaded to HisTrap column which is equilibrated with 10 mL 
dH2O and 5 mL Buffer A and lysate was passed from column (2 times). Column was 
washed with 5 mL Buffer A and passed fraction from column was collected into a new 
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tube. Then, column was washed respectively, 3 mL Buffer A + 100 mM imidazole, 5 
mL Buffer A + 200 mM imidazole, 3 mL Buffer A + 400 mM imidazole. Finally, 
column was washed with 10 mL Buffer B and fraction was collected into a new falcon 
tube. 
2.2.12 SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) 
Tricine/polyacrylamide gel with 12% acrylamide concentration was prepared for 
expressed cmFDH which was expected to be around 32-45 kDa. Contents of each part 
of gels are shown in Table 2.13 and 2.14. 
Table 2.13 : 12% separating gel solution (5 ml). 
Contents Volume 
40% acrylamide-bisacrylamide 1.5 mL 
Tris-HCl (pH: 8.8, 1.5 M) 1.3 mL 
10% SDS 50 μl 
10% APS 50 μl 
TEMED 5 μl 
dH2O 2 ml 
Table 2.14: 5% separating gel solution (2 ml). 
Contents Volume 
40% acrylamide-bisacrylamide 0.25 mL 
Tris-HCl (pH: 6.8, 1 M) 0.25 mL 
10% SDS 20 μl 
10% APS 20 μl 
TEMED 5 μl 
dH2O 1.4 ml 
The separating gel solution was performed into the gel cassette up to ± 6.5 cm, and, 
the last ± 2.5 cm of the cassette was filled with isopropanol for upper part of gel is 
smooth, immediately. After the gel was polymerized, the isopropanol was removed by 
use of filter papers. The stacking gel solution was directly poured into the gel cassette, 
and the gel comb was placed to form the slots. The stacking gel was waited to 
polymerized. 
The samples were denaturated at 95ºC for 10 min and were loaded on the SDS-PAGE 
gel. As molecular weight marker, Unstained Protein Molecular Weight Marker 
(Thermo Scientific) which contains 7 unstained protein bands in the range of 14.4-116 
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kDa was used and was loaded on the gel. Samples was run at SDS-PAGE firstly 110 
V until samples reach to stacking gel, then, gel was run at 180 V. 
After electrophoresis, SDS-PAGE was stained in CBB stain solution and gel was 
waited overnight on shaker for dying completely. Finally, it was destained in destain 
solution about 30 minutes and gel was kept into dH2O. 
2.2.13 Bradford protein assay 
Quantification of cmFDH was performed by Bradford protein assay according to 
manufacturers (BioRad) protocol as follows : 195 μl of 1x dye reagent was put into 
each 10 well. 5 μl of bovine serum albumin (BSA) was pipetted onto each 8 well in 
certain concentrations between 0 to 2 mg/ml. 5 μl of protein samples that contain 
unknown concentrations were added into the last 2 well. Plate was kept in dark for 5 
minutes and colorimetric mesaurement was performed at 595 nm for 10 seconds by 
manufacturers device (Perkin Elmer). 
2.2.14 cmFDH protein activity assay 
Activity of cmFDH protein was measured by using NAD+ and formate coupled assay. 
For this purpose, we measured towards changing substrate concentration for 
determined cmFDH enzyme activity. Reaction was prepared as 200 μl which contains 
50 μl cmFDH enzyme, 50 μl NAD+ mixture (final concentration: 1 mM) and 100 μl 
substrate mixture (final concentration: 0-40 mM). Reaction was performed at the room 
temperature (25 oC) with varying formate concentrations by the spectrophotometer 
under 340 nm wavelength. Preparation of the NAD+ mixture and substrate mixture 
were given at below: 
NAD+ mixture: 27.42 mg NAD+ was weighed and dissolved in 10 ml Tris-HCl pH: 
8.0 (4 mM) 
Substrate mixture: 272 g sodium formate was weighed and dissolved in 50 ml Tris-
HCl pH: 8.0 (80 mM). Then, 80 mM solution was diluted to used concentrations with 
Tris-HCl pH: 8.0. 
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 RESULTS 
 Mutagenesis PCR Control 
In order to obtain mutant cmFDH, we carried out the PCR. After that, agarose gel 
electrophoresis was performed to verify the product of site-directed mutagenesis PCR. Our 
product consists of nearly 6000 bp (4758 bp pQE-2 vector + 1094 bp cmFDH gene) which was 
monitored under the UV light. Agarose gel image of mutant PCR product is given in Figure 
3.1. 
 
Figure 3.1 : Agarose gel image of  mutagenesis PCR product. (a) Agarose gel image of K328V. 
M: Marker 3 (λ DNA / EcoRI + Hind III (Fermentas)); 21226 bp, 5184 bp, 4973 bp, 
4268bp, 3530 bp, 2027 bp, 1904 bp, 1584 bp, 1375 bp, 947 bp, 831 bp, 564 bp. HF 
and GC are the PCR products of mutant K328V. HF DpnI and GC DpnI are the PCR 
products of mutant K328V which were treated with DpnI enzyme. (b) Marker 3 (λ 
DNA / EcoRI + Hind III (Fermentas)). 
a b 
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 Mutation Confirmation with SacI/PstI restriction enzyme 
Confirmation of mutation, which contains desired positions’ alteration, PCR products were 
restricted by SacI/PstI restriction enzymes. Agarose gel electrophoresis was performed with 
SacI/PstI restriction enzymes for determination of insert and vector (Figure 3.2). 
 
 
Figure 3.2 : Restriction of the Q105R/K328V plasmids with SacI/PstI enzyme. M: Marker 3 
(λ DNA / EcoRI + Hind III (Fermentas)); 21226 bp, 5184 bp, 4973 bp, 4268bp, 3530 
bp, 2027 bp, 1904 bp, 1584 bp, 1375 bp, 947 bp, 831 bp, 564 bp. 1, 2, 3, 4: 
Q105R/K328V plasmids. 
 Transformation 
After the PCR which their products were checked on agarose gel electrophoresis, PCR product 
that includes mutation Q105R and Q105R/K328V was digested with DpnI enzyme. Digested 
samples were transformed into chemically competent BL-21 cells. Image of colonies obtained 
after transformation are shown at Figure 3.3. 
pQE-2 vector 
4758 bp 
cmFDH (insert) 
1096 bp 
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Figure 3.3 : Transformation of CmFDH cells (a)Q105R cell colonies as result of 
transformation. (b) Q105R/K328V colonies as a result of transformation. 
 Plasmid isolation 
Subsequently the transformation, three random colonies were chosen on Q105R/K328V plate. 
Plasmid isolation was done for these three colonies by using StrataPrep Plasmid Miniprep Kit-
Agilent. Accuracy of isolated plasmids were checked by agarose gel electrophoresis (Figure 
3.4). 
                                           
Figure 3.4 : Agarose gel image of CmFDH plasmids. (a) Agarose gel image of Q105R and 
Q105R/K328V plasmids. M: Marker 3 (λ DNA / EcoRI + Hind III (Fermentas)); 
21226 bp, 5184 bp, 4973 bp, 4268bp, 3530 bp, 2027 bp, 1904 bp, 1584 bp, 1375 bp, 
947 bp, 831 bp, 564 bp. 1, 2, 3: Q105R/K328V plasmid, 4: Q105R plasmid. (b) 
Marker 3 (λ DNA / EcoRI + Hind III (Fermentas)). 
a b 
a b 
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 Accuracy of DNA sequencing 
To determine K328V mutation, Q105R and Q105R/K328V plasmids were sequenced with 
pQE-2 promoter and reverse primer. BioEdit programme was used to compare the base changes 
with sequence of Q105R and Q105R/K328V plasmids are shown at Figure 3.5 and 3.6. 
 
Figure 3.5. Sequences alignment of the Q105R. 
 
Figure 3.6. Sequences alignment of the Q105R/K328V. 
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 Protein Purification Control (SDS-PAGE) 
After the accuracy of mutation, Q105R and Q105R/K328V plasmids were transformed into 
BL-21 cells and proteins were overexpressed by inducing with IPTG, which provides 
overexpression of desired protein. Protein purification was done by using Ni-NTA HisTrap 
column. Protein samples were ckecked by SDS-PAGE for determination of protein purity. 
According to SDS-PAGE result, the pure bands were collected and were diluted bu using 
ultrafilteration. These ultrafiltered enzymes will be used for steady-state kinetic experiments. 
Protein bands were observed around 45 kDa seen at Figure 3.7. 
                                                                         
Figure 3.7 : SDS-PAGE analysis of CmFDH protein samples. (a)SDS-PAGE analysis of 
Q105R/K328V protein samples. M: Marker 116.0 kDa, 66.2 kDa, 45.0 kDa, 35.0 
kDa, 25.0 kDa, CL: clarified lysate, E1-E5: Elution 1-5. (b) SDS-PAGE analysis 
of Q105R protein samples. M: Marker 116.0 kDa, 66.2 kDa, 45.0 kDa, 35.0 kDa, 
25.0 kDa, CL: clarified lysate, E1-E4: Elution 1-4. (c) Unstained Protein Ladder 
(Thermo Scientific Fisher). 
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 Steady-State Kinetics 
After the SDS-PAGE analysis, E3 and E4 fractions were collected and both samples were 
combined. Until final volume (50 ml), 50 mM Tris-HCl pH: 8.0 solution was added into 
collected fractions. The enzymes were centrifuged to use ultrafiltration tubes for several times 
(Until obtaining nearly 5 ml enzyme). According to Bradford protein assay, we measured 
Q105R and Q105R/K328V separately in the result of 0.731-0.337.After that, kinetic 
measurements were performed at 25 oC for collected enzymes. Reaction mixture which includes 
50 µl enzyme, 50 µl 1 mM NAD+ and 100 µl substrate mixture (0-40 mM) was prepared from 
sodium formate. All measurements for the kinetic activity was made as twice. Hyper32 
programme was used to analyse the Km and kcat value and Michelis-Menten graphs which are 
given at Figure 3.8 and 3.9 were graphed for Q105R and Q105R/K328V enzymes. Km and kcat 
values and specific activity of Q105R and Q105R/K328V enzymes are shown at Table 3.1, 3.2 
and 3.3. 
Table 3.1 : Specific activity of Q105R. 
Final Concentrations of 
Substrate (formate) (mM) 
Slope Specific Activity  
(µmol/sec.mg) 
0 0 0 
1 0,0833 0,00222783 
2 0,1288 0,003444711 
3 0,1643 0,004394147 
5 0,2245 0,006004175 
7,5 0,2697 0,007213033 
10 0,29755 0,007957872 
12,5 0,28525 0,007628913 
15 0,2921 0,007812113 
17,5 0,2955 0,007903045 
20 0,3027 0,008095607 
22,5 0,30495 0,008155782 
25 0,3101 0,008293517 
30 0,3148 0,008419217 
40 0,3192 0,008536894 
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Figure 3.8 : Michelis-Menten graph of Q105R. 
Table 3.2 : Specific activity of Q105R/K328V. 
Final Concentrations of 
Substrate (formate) (mM) 
Slope Specific Activity 
(µmol/sec.mg) 
0 0 0 
1 0,02385 0,001383607 
2 0,0416 0,002413336 
3 0,058 0,003364747 
5 0,0778 0,004513402 
7,5 0,10405 0,006036241 
10 0,11775 0,006831017 
12,5 0,1269 0,007361835 
15 0,13205 0,007660601 
17,5 0,1467 0,00851049 
20 0,1594 0,009247254 
22,5 0,16085 0,009331372 
25 0,17275 0,010021726 
30 0,1957 0,011353122 
40 0,20905 0,012127594 
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Figure 3.9 : Michelis-Menten graph of Q105R/K328V. 
Table 3.3 : Km and kcat values of studied enzymes. 
Enzyme Km (mM) kcat (sn-1)  kcat/Km (sn-1 mM-1) 
Q105R 2.963±0.5959 0,384621 0,129808 
K328V + Q105R 12.77±3.068 0,62976 0,049316 
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 DISCUSSION 
In this study, we aimed to increase specific activity of NAD+-dependent mutant Q105R 
Candida methylica formate dehydrogenase (cmFDH) which has increased thermostability [35]. 
For this purpose, 328th amino acid position was determined from Candida boidinii organism 
that shows nearly 98% similarity with Candida methylica according to Schirwitz’s article [7]. 
We expected that Km value was increased when compared to that study. However, 
unexpectedly, specific activity of cmFDH carrying double mutant (Q105R/K328V) did not 
increase. In K328V mutation, we converted lysine to valine amino acid. As known, lysine is a 
positively charged amino acid and valine is a neutral charged amino acid residue.  Therefore, 
K328V position changes could have been negatively affect affinity of our mutant enzyme. The 
other reason of decrasing the activity of enzymes could be occured because of the amino acid 
size since valine has too small size when compared to lysine. This situtation can also affect 
interaction of substrate with the enzyme’s active site. 
To overcome the low specific activity of Candida methylica formate dehydrogenase, alternative 
mutants can be applied on Q105R thermostabile mutant.
36 
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 CONCLUSIONS 
NAD+-dependent formate dehydrogenase (EC 1.2.1.2) belongs to oxidoreductase 
family. NAD+ and sodium formate are reduced to NADH and CO2 by formate 
dehydrogenase in the organisms. Formate dehydrogenase is used in various application 
such as chemistry and industrial area because of their great potential. However, in 
industrial process, some extreme conditions can affect activity of these enzymes such 
as high temperature, pressure and pH. Therefore, they have limited activity when used 
in reactions. Recently, protein engineering studies have helped for solving limitation 
problem and improving the enzyme functionality. 
In this study, we used site-directed mutagenesis technique for increasing specific 
activity of Q105R mutant which is accepted as the most thermostabile cmFDH [35]. 
Firstly, we designed a primer set for the alteration of lysine into valine at 328th  position 
(K328V). After that, we performed PCR in order to amplify the mutant gene.  Agarose 
gel electrophoresis is performed to visualize the PCR products. Then, mutant cells 
were incubated and overexpressed for producing more protein. SDS-PAGE was 
applied to the protein samples. Finally, enzymatic activity of Q105R/K328V mutant 
was measured at constant NAD+ and various substrate concentrations. As a result of 
the study, while Km value of Q105R/K328V was decreased, kcat value was increased. 
In the further studies, alternative mutants will be constructed by using the Q105R  
mutant as a template to increase the specific activity of thermostabile cmFDH. 
Thermostability experiments of double mutant will also be analysed.  
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